EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles

Samane Teymouri, Maryam Pourhajibagher, Abbas Bahador

Molecular Biology Reports · 2024

DOI: 10.1007/s11033-024-09979-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Samane Teymouri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Nanoparticles, Anti-Bacterial Agents, Bacteriophages. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 129 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the current era of antibiotic resistance, researchers are exploring alternative ways to treat bacterial infections that are resistant to multiple drugs. Acinetobacter baumannii (A. baumannii) is a bacterium that is commonly encountered in clinical settings and is known to be resistant to several drugs. Due to the increase in drug-resistant infections caused by this bacteria, there is an urgent need to investigate alternative treatment options such as phage therapy and combination therapy. Despite the success of phages in some cases, there are some limitations in their clinical application that can be overcome by combining phages with other substrates such as nanoparticles to improve their function. The integration of nanotechnology with phage therapy against A. baumannii promises to overcome antibiotic resistance. By exploiting the targeted delivery and controlled release capabilities of nanoparticles, we can enhance the therapeutic potential of phages while minimizing their limitations. Continued research in this field will undoubtedly pave the way for more effective and precise treatments against A. baumannii infections and provide hope in the fight against antibiotic-resistant bacteria.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiNanoparticlesAnti-Bacterial AgentsBacteriophagesPhage TherapyAcinetobacter InfectionsHumansDrug Resistance, Multiple, BacterialAnimals

Stichwörter der Autor:innen

Acinetobacter baumanniiAntibiotic therapyPhage therapyPhage-nanotechnology therapy

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. m-pourhajibagher@sina.tums.ac.ir.
  • Dental Research Center, Dentistry Research Institute, Tehran University of Medical Sciences, Tehran, Iran. m-pourhajibagher@sina.tums.ac.ir.
  • Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. abahador@sina.tums.ac.ir.
  • Fellowship in Clinical Laboratory Sciences, BioHealth Lab, Tehran, Iran. abahador@sina.tums.ac.ir.

Zitieren

APA

Teymouri, S., Pourhajibagher, M., & Bahador, A. (2024). A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09979-4

Vancouver

Teymouri S, Pourhajibagher M, Bahador A. A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09979-4

BibTeX
@article{Teymouri2024,
  author = {Teymouri, Samane and Pourhajibagher, Maryam and Bahador, Abbas},
  title = {A review of the fighting Acinetobacter baumannii on three fronts: antibiotics, phages, and nanoparticles},
  journal = {Molecular Biology Reports},
  year = {2024},
  doi = {10.1007/s11033-024-09979-4}
}
Kostenlos starten →